Semaglutide for overweight and obesity: NICE technology appraisal
Posted 20 May 2024
Dr Anish Kotecha summarises NICE’s 2023 recommendations on the use of semaglutide for managing overweight and obesity in adults.
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page